Adaptimmune Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.6M | 2.1M | 0.78 |
| 2023-06-30 | $1.9M | 2.1M | 0.94 |
| 2022-12-31 | $3.3M | 2.3M | 1.46 |
| 2022-06-30 | $3.0M | 2.1M | 1.45 |
| 2022-03-31 | $0 | 2.1M | 0.00 |
| 2021-06-30 | $0 | 2.3M | 0.00 |
| 2020-12-31 | $29M | 5.4M | 5.39 |
| 2020-09-30 | $2.4M | 295k | 7.98 |
| 2020-06-30 | $380k | 38k | 10.02 |
| 2020-03-31 | $77k | 29k | 2.68 |
| 2019-12-31 | $31k | 26k | 1.21 |
| 2019-09-30 | $609k | 404k | 1.51 |
| 2019-03-31 | $1.0M | 237k | 4.30 |
| 2018-12-31 | $284k | 49k | 5.77 |
| 2018-09-30 | $112k | 8.3k | 13.54 |
| 2018-06-30 | $2.9M | 248k | 11.87 |
| 2018-03-31 | $1.8M | 157k | 11.23 |
| 2017-12-31 | $406k | 61k | 6.69 |
| 2017-03-31 | $48k | 8.7k | 5.53 |
| 2016-09-30 | $25k | 3.6k | 7.00 |
| 2016-06-30 | $67k | 8.2k | 8.20 |
| 2016-03-31 | $78k | 9.6k | 8.09 |
| 2015-12-31 | $58k | 5.2k | 11.17 |
| 2015-09-30 | $30k | 2.5k | 11.82 |
| 2015-06-30 | $211k | 12k | 18.32 |